Four new autoantigens trigger multiple sclerosis
Despite considerable progress in the treatment of multiplesclerosis (MS), the disease still often leads to permanent neurological disability....
Syndesi swallowed by Abbvie
Originally, Belgian Syndesi was created in 2017 through a partnership between UCB Biopharma SRL and a syndicate of Belgian and international...
Engimmune Therapeutics raises CHF15.5m in seed financing
Pureos Bioventures and Novo Holdings co-led the financing of Engimmune Therapeutics, a spin-off from the research group of Prof. Sai Reddy at the...
Bayer Leaps to invests €1.3bn externally
"We are on the threshold of a new era of innovation in the life sciences." commented Werner Baumann, Chairman of the Board at Bayer...
Switzerland paves the way for genome editing
Following in the footsteps of the UK, Switzerland wants to exempt genome editing and targeted mutagenesis in plant breeding from the Swiss Genetic...
TargED Biopharmaceuticals BV raises €39m in Series A financing
Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures participated in the financing. Seed investors FIRST...
